Itching, or pruritus, is a common symptom that affects millions of people around the world. It can range from a mild annoyance to a debilitating condition. Although it is not life-threatening, it can cause significant physical and psychological distress. The International Classification of Diseases, 10th revision (ICD-10) classifies itching as a symptom, which can be caused by a variety of underlying conditions. This article will explore the causes and treatments of itching, as classified by the ICD-10.
The ICD-10 classifies itching as a symptom, which can be caused by a variety of underlying conditions. These conditions can be divided into three main categories: skin diseases, systemic diseases, and external causes.
Skin diseases are the most common cause of itching. These include conditions such as eczema, psoriasis, scabies, and contact dermatitis. Eczema is a chronic inflammatory condition of the skin that causes itching, redness, and dryness. Psoriasis is a chronic skin condition characterized by thick, scaly patches of skin. Scabies is an infestation of the skin by mites, which causes intense itching. Contact dermatitis is an allergic reaction to certain substances that come into contact with the skin, such as certain soaps, detergents, and cosmetics.
Systemic diseases are conditions that affect the entire body, rather than just the skin. These can cause itching due to the release of certain substances in the body. Examples of systemic diseases that can cause itching include kidney disease, liver disease, and certain types of cancer. Kidney disease can cause itching due to the buildup of waste products in the body. Liver disease can cause itching due to the accumulation of bile acids in the skin. Certain types of cancer can cause itching due to the release of certain hormones or proteins.
External causes of itching include insect bites, sunburn, and certain medications. Insect bites can cause itching due to an allergic reaction to the saliva of the insect. Sunburn can cause itching due to the inflammation of the skin. Certain medications, such as antibiotics and nonsteroidal anti-inflammatory drugs, can cause itching as a side effect.
The treatment of itching depends on the underlying cause. For skin diseases, treatments may include topical medications, such as corticosteroids, or light therapy. For systemic diseases, treatments may include medications to treat the underlying condition, as well as medications to help reduce the itching. For external causes, treatments may include topical medications, such as antihistamines, to reduce the itching.
Itching is a common symptom that can be caused by a variety of underlying conditions. The International Classification of Diseases, 10th revision (ICD-10) classifies itching as a symptom, which can be caused by skin diseases, systemic diseases, and external causes. Treatment of itching depends on the underlying cause, and may include topical medications, medications to treat the underlying condition, or light therapy. It is important to seek medical advice if itching persists, as it can cause significant physical and psychological distress.
1.
Next Day Mood Is Affected by Ability to Recover From Work.
2.
Enhanced CAR T cell therapy offers new strategy for lymphoma
3.
With the use of a novel sequencing technique, pediatric bone marrow transplant mortality can be predicted by analyzing lung microbiomes.
4.
Decrease seen in in situ breast cancer since 2009
5.
Scientists hail the cervical cancer treatment as the most remarkable breakthrough in 20 years.
1.
Discovering the Benefits of TNK: A Comprehensive Blog Article
2.
Rare Malignant Ovarian Tumors: A Comprehensive Review for Clinicians
3.
Revolutionizing Cancer Treatment with Darzalex: How an Innovative Drug is Transforming Lives
4.
Personalized Cancer Vaccines: The Next Frontier in Precision Oncology
5.
Precision Medicine and Genomics: Revolutionizing Healthcare Through Personalized Treatment
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Influence of CDK4/6 Inhibitors in Extending Progression-Free Survival (PFS) and Overall Survival in HR+/HER2- mBC Patients
2.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part II
3.
Managing ALK+ NSCLC while Ensuring Long-Term Safety of the Patients
4.
Dissecting Molecular differences between EGFR Exon 19 deletion and Exon 21 L858R Mutations
5.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management- Further Discussion
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation